 |
Growth hormone releasing factor |
|---|---|
| Trade Name | |
| Orphan Indication | For the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion |
| USA Market Approval | USA |
| USA Designation Date | 1989-08-07 00:00:00 |
| Sponsor | Valeant Pharmaceuticals North America;700 Route 202/206;Bridgewater, New Jersey, 08807 |
